Closing
Entering 2007, our company is well positioned to continue creating value for customers and shareholders. Our balance sheet is strong, bolstered by the addition of low cost debt during 2006. We managed down our capital spending during the year and expect the level of capital investment required in 2007 to be substantially less than that of the prior two years. Our enhanced process capabilities will strengthen our ability to satisfy long-term growth in suspension assembly demand, as well as requirements driven by disk drive and suspension assembly miniaturization. In our BioMeasurement Division, commercial launch of our InSpectra™ StO2 Tissue Oxygenation Monitor has begun.
We thank our people for their dedication and effort in 2006. They collectively create and sustain the culture of excellence that is our company’s distinctive strength and key source of competitive advantage. We look forward to the new year with excitement and confidence.
Wayne M. Fortun
President and
Chief Executive Officer
John A. Ingleman
Sr. Vice President and
Chief Financial Officer
|
